Stay updated with breaking news from Amy Rasley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new discovery shows promise against the neurological effects of Lyme disease. Scientists may have found a way to effectively counter the neurological symptoms of Lyme disease.
SAN FRANCISCO (KGO) -- While COVID-19 is by far the most widespread threat, it's also just the latest in a progression of dangerous viruses, including the deadly outbreak of SARS in the early 2000s, and another known as MERS that emerged first in the Middle East. Now, Stanford Researcher Peter Kim, Ph.D., and his team are on the trail of a vaccine that's cheap and easily transportable. "Our goal was to create a vaccine that was protein only, that would be a single shot vaccine and would be room temperature stable. And our hope is that such a vaccine could be used in lower-middle income countr...
Bay Area researchers developing COVID vaccine to protect against future variants KTVU's Tom Vacar reports. LIVERMORE, Calif. - A Bay Area laboratory is helping come up with the technology that could make worldwide pandemics far easier and quicker to defeat. The Lawrence Livermore National Laboratory, which assures the safety, security, and reliability of America's nuclear weapons, is working to develop a vaccine to protect against future mutations. Lawrence Livermore National Laboratory (LLNL) partnered up with UK biotech company ConserV Bioscience to create a universal coronavirus vaccine....
Lawrence Livermore National Laboratory announced this week a new collaboration with a United Kingdom company to develop a broad-spectrum or "universal" coronavirus vaccine.
Share this article Share this article LONDON, Jan. 19, 2021 /PRNewswire/ -- ConserV Bioscience Limited ("ConserV"), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and Lawrence Livermore National Laboratory ("LLNL") have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine. This collaboration brings together ConserV's expertise in identifying antigens and Lawrence Livermore National Laboratory's nanolipoprotein particle technology ("NLP") delivery system. The vaccine has been desi...